Eurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testing LOUISVILLE, KY — Eurofins Genomics U.S. announces that, together with its subsidiary BlueHeron Biotechnology, it has launched a series of SARS-CoV-2 plasmid DNA controls that can be […]
CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of antibody tests for COVID-19. Since the emergence of COVID-19 outbreaks in January, Meridian has supported molecular diagnostic companies with critical master mixes and enzymes for their COVID-19 Molecular Diagnostics tests. To meet the massive need for […]
Turin-Italy and Utrecht-the Netherlands — The ultra-modern Department of Molecular Biotechnology and Health Sciences of the University of Turin has acquired MILabs cutting edge multi-modality VECTor6CT molecular imaging system. The high-resolution and ultra-sensitive PET, SPECT and CT modalities will be used by UNITO to optimize the targeting vectors of novel probes for disease diagnostics and […]
IDT’s new panel includes the Iowa Black-ZEN quencher probe technology recently approved for use in existing CDC EUA testing protocol Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced a significant expansion of its coronavirus product line with the addition of primer-probe kits equivalent to the primer and probe ratios described in the WHO-Charité/Berlin (“WHO”) […]
Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion SAN ANTONIO, TX – Investigators exploring chondrocytes in vitro have the ability to study a more biologically-relevant phenotype with CELLvo™ Human Articular Chondrocytes from StemBioSys. Isolated from healthy donors, CELLvo™ Chondrocytes are available to scientists before being cultured at passage 0, or […]
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes Supports global efforts to develop therapeutics, diagnostic assay components and vaccines to combat the COVID-19 Coronavirus pandemic Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene […]
Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its COVID-19 vaccine candidate, ChAdOx1 nCoV-19. DARMSTADT, GERMANY Recently developed manufacturing platform allows large-scale manufacturing Joint team reduced process development time to two months from a year – a critical step to manufacturing COVID-19 vaccine at […]
MGI has announced a major upgrade for DNBSEQ-G50 with improvements to flexibility, turnaround time and performance. The original FC (Flow Cell) with 300M total reads is upgraded to FCL (Flow Cell Large) with 500M total reads, and a new FCS (Flow Cell Small) has been released with total reads of 100M. In addition, a longer […]
Bournemouth, UK and Newark, CA, USA – Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening orders of magnitude fewer […]
Carlsbad, CA – On February 26, 2020, Active Motif announced the successful isolation of antibodies from patients in China recovering from 2019 Coronavirus related pneumonia (COVID-19). The full suite of antibodies is now available for research as well as commercial applications. “The discovery and expression of a full human antibody against the COVID-19 virus is […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
